Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Authors: Nicholas J. Viney, Julian C. van Capelleveen, Richard S. Geary, Shuting Xia, Joseph A. Tami, Rosie Z. Yu, Santica M. Marcovina, Steven G. Hughes, Mark J. Graham, Rosanne M. Crooke, Stanley T. Crooke, Joseph L. Witztum, Erik S.G. Stroes, Sotirios Tsimikas - The Lancet 2016 cited by 748